Golestan University of Medical Sciences Repository

The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR

Janbabai, G. and Oladi, Z. and Farazmandfar, T. and Taghvaei, T. and Naghshvar, F. (2015) The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR. Journal of Cancer Research and Clinical Oncology, 141 (11). pp. 1945-1952.

[img]
Preview
PDF - Published Version
Download (830kB) | Preview

Abstract

Purpose: Identification of critical genes which play pivotal roles in controlling tumor growth and survival will establish the basis for developing therapeutic targets. In this study, we focused on frequencies of EGFR, ErbB2 and MET gene amplification in gastric cancer patients to develop personalized medicine to improve the treatment. Method: EGFR, ErbB2 and MET gene amplification, and mRNA expression were analyzed by the quantitative Real-Time PCR in paraffin-embedded samples from 115 patients with gastric cancer. Results: EGFR, ErbB2 and MET genes were amplified in 11.3 % (13/115), 6.1 % (7/115) and 19.1 % (22/115) of cancerous specimens, respectively. The correlation coefficient test clearly indicated that gene amplification in these three genes was positively correlated with mRNA transcription (EGFR: R = 0.631, p = 0.009; ErbB2: R = 0.652, p = 0.023; MET: R = 0.715, p < 0.001). EGFR and MET gene amplification was significantly associated with Ki-67 MI (p = 0.022 and p = 0.015). MET amplification was also significantly associated with age of ≥60 years (p = 0.021) and tumor size of ≥5 cm (p = 0.032). MET amplification, but not EGFR and ErbB2, was a significant prognostic factor in poor survival among patients with gastric cancer. Conclusions: EGFR, ErbB2 and MET genes are frequently amplified in gastric carcinoma. EGFR, ErbB2 and MET gene amplification is positively correlated with mRNA transcription. MET gene amplification correlates with a poor prognosis and poor survival in gastric carcinomas. © 2015, Springer-Verlag Berlin Heidelberg.

Item Type: Article
Additional Information: cited By 3
Uncontrolled Keywords: epidermal growth factor receptor; epidermal growth factor receptor 2; Ki 67 antigen; messenger RNA; EGFR protein, human; epidermal growth factor receptor; epidermal growth factor receptor 2; ERBB2 protein, human; messenger RNA; MET protein, human; scatter factor receptor, adult; Article; cancer prognosis; cancer staging; cancer surgery; cancer survival; controlled study; correlation coefficient; female; gene amplification; gene dosage; gene expression; genetic association; human; major clinical study; male; MET gene; overall survival; priority journal; real time polymerase chain reaction; stomach carcinoma; tumor differentiation; tumor gene; tumor volume; biosynthesis; copy number variation; gene amplification; genetics; middle aged; real time polymerase chain reaction; stomach tumor, DNA Copy Number Variations; Female; Gene Amplification; Gene Dosage; Humans; Male; Middle Aged; Proto-Oncogene Proteins c-met; Real-Time Polymerase Chain Reaction; Receptor, Epidermal Growth Factor; Receptor, ErbB-2; RNA, Messenger; Stomach Neoplasms
Subjects: مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: معاونت تحقیقات و فناوری
Depositing User: GOUMS
Date Deposited: 08 Sep 2016 09:40
Last Modified: 14 Jan 2017 07:41
URI: http://eprints.goums.ac.ir/id/eprint/4655

Actions (login required)

View Item View Item